Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-131461 in congestive heart failure with volume overload
NCT05615363Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OPC-131461 in heart failure (HF), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jan 2023; status: completed.
02
Drugs
OPC-131461
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05615363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05615363.